NHS funds device to protect prostate cancer patients during radiation treatment

A device, which can reduce the side-effects of radiotherapy for prostate cancer patients by more than 70%, will be rolled out across the NHS, as part of The NHS Long Term Plan to put cutting-edge treatments at the heart of people’s care. Hospitals in England will now be encouraged to use a hydrogel device for all patients who could benefit, making radiotherapy a safer and less painful treatment option for many men. As part of its ambition to save tens of thousands more lives over the next decade, the NHS is also introducing new ‘one stop shops’ across the country to speed up cancer diagnosis.